Columns

Pharma Insights
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
Elizabeth Oyekan, PharmD, FCSHP, CPHQ February 22, 2021
CME Corner
Treatment Challenges in Peripheral T-Cell Lymphoma
Jasmine M Zain, MD, City of Hope Cancer Center, Duarte, CA, April 21, 2020
Jasmine M Zain, MD, highlights treatment options and standard of care in Peripheral T-Cell Lymphoma as well as…
Trending From ACCC
Financial Advocacy Network: Hub for Education, Resources, and Peer-to-Peer Learning
JCP Editors, March 16, 2020
The ACCC Financial Advocacy Network online hub includes resources such as financial advocacy services guidelines, a…
Pharma Insights
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Avi Mamidi, PharmD; Elizabeth Oyekan, PharmD, FCSHP, CPHQ; Jeremy Schafer, PharmD, MBA; Larry Blandford, PharmD—Column Editor, March 16, 2020
Avi Mamidi, PharmD, and colleagues posit that making value-based care the new normal in health care will require health…
Engaging Payers
Building Episodes of Care Models for Oncology & Other Chronic Conditions
Lili Brillstein, MPH—Column Editor, March 16, 2020
Lili Brillstein, MPH, asserts that the benefits of the episodes of care model is far-reaching and is worth the effort…
Clinical Pathways GPS
Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor; Matthew Pakizegee, PharmD, MS; Jonathan W Hodgson, MBA; Chad McAuliffe, March 16, 2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD, and colleagues pose that if aducanumab is approved by the FDA,…
CME Corner
Making the Switch to Biosimilars With Clinical Pathways
Gary H Lyman, MD, MPH, FASCO, FRCP, FACP, March 16, 2020
Gary H Lyman, MD, MPH, FASCO, FRCP, FACP, discusses the most compelling reason to incorporate biosimilars into clinical…
CME Corner
Navigating the Complexities of Novel Treatment Sequencing for AML
Daniel A Pollyea, MD, MS, March 16, 2020
Daniel A Pollyea, MD, MS, discusses the new therapies that are set to augment and possibly replace intensive…
Trending From ACCC
2019 ACCC Survey Respondents Recognize Care Standardization as Opportunity for Cost Savings
JCP Editors, February 18, 2020
Results of the 2019 survey show that 43% of respondents plan to add or grow financial advocacy services in the next 12…
Tools for Transformation
Recognizing the Limitations Surrounding Clinical Pathways to Ensure Appropriate Use
Gordon Kuntz—Column Editor, February 18, 2020
Gordon Kuntz, Partner, Kuntz Consulting, argues that while oncology clinical pathways are one of the single most…
Pharma Insights
Where Will Health Care Take Us in the 2020s?
David Carr, PhD; Larry Blandford, PharmD—Column Editor, February 18, 2020
David Carr, PhD, and Larry Blandford, PharmD, review prevailing trends in health care and project what they believe are…
Back to Top